PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Nov-2023 New Frequency Comb Can Identify Molecules in 20-Nanosecond Snapshots TOPTICA Photonics AG
02-Nov-2023 FDA (Food and Drug Administration) Approval Process for Medical Devices Online Training Course - ResearchAndMarkets.com Businesswire
02-Nov-2023 Baxter Reports Third-Quarter 2023 Results Businesswire
02-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Nov-2023 Satellos to Present at the Stifel 2023 Healthcare Conference Businesswire
02-Nov-2023 ANGANY Appoints Christine Guillen as CEO, Announces Strengthening of Its Executive Committee Businesswire
02-Nov-2023 Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day Businesswire
02-Nov-2023 TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’ Businesswire
02-Nov-2023 ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results Businesswire
02-Nov-2023 KalVista Pharmaceuticals to Present Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology Businesswire
02-Nov-2023 Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results Businesswire
02-Nov-2023 Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit Businesswire
02-Nov-2023 Il Comitato per il ripristino del valore per gli azionisti Nymox desidera rammentare a tutti gli azionisti Nymox Pharmaceutical di agire e richiedere responsabilità in occasione dell’imminente Riunione speciale che si terrà l’8 novembre Businesswire
02-Nov-2023 Le Committee to Restore Nymox Shareholder Value rappelle à tous les actionnaires de Nymox Pharmaceutical la nécessité d’agir et d’exiger des comptes lors de l’Assemblée extraordinaire du 8 novembre prochain Businesswire
02-Nov-2023 Das Committee to Restore Nymox Shareholder Value erinnert die Aktionäre von Nymox Pharmaceutical daran, auf der bevorstehenden außerordentlichen Hauptversammlung am 8. November Maßnahmen zu ergreifen und Rechenschaft zu verlangen Businesswire
02-Nov-2023 The Committee to Restore Nymox Shareholder Value herinnert alle aandeelhouders van Nymox Pharmaceutical eraan om actie te ondernemen en verantwoording te eisen tijdens de Bijzondere Vergadering van 8 november aanstaande Businesswire
02-Nov-2023 MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting MorphoSys AG
02-Nov-2023 Amazon’s healthy 13% sales rise is the prescription for a booming UK online healthcare market London Medical Laboratory
02-Nov-2023 Latham BioPharm Group Awarded NIAID Preclinical Services IDIQ Contract Valued at Up to $30 Million Newswire
02-Nov-2023 Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results Businesswire